Stephen Fleming
Psychiatry · Athens, GANPI 1265639835
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.1% of the total across 112 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Neuronetics, Inc. at 25.7% of the total. Reporting peaked in 2019 at $1,139 and has fallen 88.4% since, to $133 in 2025.
Across 112 payments — averaging $27.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuronetics, Inc.$787
- Takeda Pharmaceuticals U.S.A., Inc.$524
- AbbVie$309
- Lundbeck LLC$229
- Johnson & Johnson$220
- Vanda Pharmaceuticals Inc.$199
- plus $795 from 11 others
What the payments were for
- Travel & lodging$2137%
- Food & beverage$2,76090%
- Education$903%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuronetics, Inc. | 5 | $787 |
| Takeda Pharmaceuticals U.S.A., Inc. | 28 | $524 |
| AbbVie(2 entities) | 19 | $309 |
| Lundbeck LLC | 13 | $229 |
| Johnson & Johnson | 9 | $220 |
| Vanda Pharmaceuticals Inc. | 9 | $199 |
| Sunovion Pharmaceuticals Inc. | 7 | $186 |
| Otsuka America Pharmaceutical, Inc. | 3 | $180 |
| Welcony Inc. | 1 | $114 |
| Teva Pharmaceuticals USA, Inc. | 4 | $62 |
| Supernus Pharmaceuticals, Inc. | 3 | $56 |
| Alkermes, Inc. | 3 | $56 |
| Neurocrine Biosciences, Inc. | 2 | $50 |
| Neos Therapeutics, LP | 3 | $42 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Corium, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,063 in reported general payments places this provider in the 80th percentile of 900 psychiatry providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Vilazodone Hcl | 17 | $1,650 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 33 | $940 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 17 | $847 |
| Bupropion XlBupropion Hcl | 11 | $252 |
| Lurasidone Hcl | 13 | $217 |
| Trazodone Hcl | 12 | $109 |
| Clonazepam | 23 | $108 |
| Clonidine Hcl | 11 | $35 |
| Alprazolam | 11 | $7 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Athens
- Jose CangianoAthens$244K
- Richard PettyLoganville$2.9M
- Ann GrooverCalhoun$1.4M
- Todd AntinDecatur$1M
- Michael BanovMarietta$733K
- Ben HunterBrookhaven$499K
- Joel MorganValdosta$337K
- Munjal ShroffSmyrna$316K
- David PurselleAtlanta$307K
- Michael BurkeAtlanta$217K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.